Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE trial
…, HM Dhillon, DJ Jonker, NS Chua, S Lupichuk… - … Biomarkers & Prevention, 2016 - AACR
Background: There is strong interest in testing lifestyle interventions to improve cancer outcomes;
however, the optimal methods for achieving behavior change in large-scale pragmatic …
however, the optimal methods for achieving behavior change in large-scale pragmatic …
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor …
D Rayson, S Lupichuk, K Potvin, S Dent… - Breast cancer research …, 2016 - Springer
In murine models, overexpression of the MET receptor transgene induces tumors with human
basal gene expression characteristics supporting MET inhibition as a treatment strategy for …
basal gene expression characteristics supporting MET inhibition as a treatment strategy for …
[HTML][HTML] Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility
Genome-wide association studies (GWASs) have identified low-penetrance common variants
(ie, single nucleotide polymorphisms, SNPs) associated with breast cancer susceptibility. …
(ie, single nucleotide polymorphisms, SNPs) associated with breast cancer susceptibility. …
The ONE‐MIND Study: Rationale and protocol for assessing the effects of ONlinE MINDfulness‐based cancer recovery for the prevention of fatigue and other common …
…, J Vallerand, M Speca, S Lupichuk… - European journal of …, 2019 - Wiley Online Library
Cancer patients often experience poor quality of life (QoL) during chemotherapy (CT) treatments
due to side effects including fatigue, insomnia, pain and nausea/vomiting. Mindfulness‐…
due to side effects including fatigue, insomnia, pain and nausea/vomiting. Mindfulness‐…
Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation
…, JM Luider, DA Stewart, T Cheng, SM Lupichuk… - Blood, 2003 - ashpublications.org
Hematologic stem cell rescue after high-dose cytotoxic therapy is extensively used for the
treatment of many hematopoietic and solid cancers. Gene marking studies suggest that occult …
treatment of many hematopoietic and solid cancers. Gene marking studies suggest that occult …
Impact of cumulative chemotherapy dose on survival with adjuvant FEC-D chemotherapy for breast cancer
…, DA Stewart, X Kostaras, K King, S Lupichuk - Journal of the National …, 2019 - jnccn.org
Background: Reductions in adjuvant chemotherapy dose <85% for historical regimens (ie,
cyclophosphamide/methotrexate/fluorouracil) are known to affect breast cancer survival. This …
cyclophosphamide/methotrexate/fluorouracil) are known to affect breast cancer survival. This …
[HTML][HTML] The association between early-onset diagnosis and clinical outcomes in triple-negative breast cancer: a systematic review and meta-analysis
…, Y Xu, ML Quan, WY Cheung, S Lupichuk… - Cancers, 2023 - mdpi.com
Simple Summary Epidemiologic studies have observed higher risks of breast cancer
recurrence and death in women diagnosed <40 years of age compared to ≥40 years. There is …
recurrence and death in women diagnosed <40 years of age compared to ≥40 years. There is …
Radiation therapy with cyclin-dependent kinase 4/6 inhibitors: a multi-institutional safety and toxicity study
…, T Abedin, CP Amaro, L Barbera, S Lupichuk… - International Journal of …, 2022 - Elsevier
Purpose Our purpose was to investigate radiation therapy (RT) toxicity when given with
cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) compared with RT alone. Methods and …
cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) compared with RT alone. Methods and …
[HTML][HTML] A smartphone app–based mindfulness intervention for cancer survivors: protocol for a randomized controlled trial
…, KAL Piedalue, M Speca, S Lupichuk… - JMIR research …, 2020 - researchprotocols.org
Background Cancer patients transitioning to survivorship after completing cancer treatments
need psychosocial interventions to manage stressors such as anxiety, depression, and fear …
need psychosocial interventions to manage stressors such as anxiety, depression, and fear …
[HTML][HTML] A review of trastuzumab biosimilars in early breast cancer and real world outcomes of neoadjuvant MYL-1401O versus reference trastuzumab
…, R Khwaja, P Tang, N Nixon, K King, S Lupichuk - Current …, 2022 - mdpi.com
The reduced cost of trastuzumab biosimilars has led to increased adoption for HER2-positive
breast cancer. This review of trastuzumab biosimilars encompasses this development and …
breast cancer. This review of trastuzumab biosimilars encompasses this development and …